Purpose The COVID-19 pandemic has forced reorganization of clinical services to minimize
face-to-face contact between patients and health-care providers. Specialist services …

There is an increasing need for genetic counseling and testing for individuals diagnosed
with cancer, as treatment may be affected by the results. In addition, the identification of …

Purpose To address demands for timely germline information to guide treatments, we
evaluated experiences of patients with ovarian, pancreatic, and prostate cancer with a …

Abstract In 2010, the National Society of Genetic Counselors (NSGC) membership was
surveyed about their use of genetic counseling service delivery models (SDMs) including in …

Background Women with epithelial ovarian cancer (OC) have a higher chance to benefit
from poly (ADP-ribose) polymerase inhibitor (PARPi) therapy if their tumor has a somatic or …

Germline genetic testing is now routinely recommended for patients with prostate cancer
(PCa) because of expanded guidelines and options for targeted treatments. However …

Background The use of proactive genetic screening for disease prevention and early
detection is not yet widespread. Professional practice guidelines from the American College …

Prognosis is generally poor for patients with pancreatic ductal adenocarcinoma. However,
patients with germline BRCA1 or BRCA2 mutations (gBRCAm) may benefit from first-line …

According to current guidelines, all women with epithelial ovarian cancer are eligible for
genetic testing for BRCA germline pathogenic variants. Unfortunately, not all affected …

Advances in the application of genomic technologies in clinical care have the potential to
increase existing healthcare disparities. Studies have consistently shown that only a fraction …